For Email Subscribers: Baupost Has Best Month In 5 Years

This is a repost for those not subscribed to our business feed, but stay tuned for Part II!

In the second quarter letter, Klarman spoke of the profits it made on investments such as Idenix Pharmaceuticals Inc (NASDAQ:IDIX). The biotech company helped make June Baupost’s best month in five years. Idenix was acquired by Merck & Co., Inc. (NYSE:MRK)’s wholly-owned subsidiary Imperial Blue Corporation. Baupost exited the investment in early August. Baupost’s returns in the second quarter were driven chiefly by its public equity portfolio, backed up by positive performance in